Turn Therapeutics Inc. 8-K

What Happened
Turn Therapeutics Inc. announced on June 1, 2026 that it issued a press release and furnished that release as an exhibit to a Current Report on Form 8-K. The filing reports the disclosure under Item 7.01 (Regulation FD Disclosure).

Key Details

• Filing date: June 1, 2026 (Form 8-K filed by Turn Therapeutics Inc.).
• Item reported: 7.01 — Regulation FD Disclosure (press release furnished).
• Exhibit furnished: Exhibit 99.1 (Press Release dated June 1, 2026).
• Other exhibit: Exhibit 104 (Cover Page Interactive Data File / Inline XBRL).

Why It Matters
This 8-K notifies investors that Turn Therapeutics has publicly released information via a press release and furnished that release with the SEC filing. Regulation FD filings are meant to ensure material information is broadly available to all investors; if you follow TTRX, review the attached press release (Exhibit 99.1) for the company’s announced details. This filing does not itself report earnings, executive changes, or other material events beyond the furnished press release.